RECRUITING
I'm interested ...!!
Lupus Education Alliance Program
The purpose of this study is to assess the assess the effect of education-only vs. navigation interventions on COVID-19 testing and vaccination for people with systemic lupus erythematosus.
Conditions:
🦠 Systemic Lupus Erythematosus 🦠 COVID-19
🗓️ Study Start (Actual) 1 November 2023
🗓️ Primary Completion (Estimated) 31 March 2025
✅ Study Completion (Estimated) 31 August 2025
👥 Enrollment (Estimated) 500
🔬 Study Type INTERVENTIONAL
📊 Phase NA
Locations:
📍 New Orleans, Louisiana, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Living with systemic lupus erythematosus (SLE),
    • * At least 18 years of age,
    • * Ability to speak and understand English, and
    • * Live, work, or seek care in Alabama or Louisiana
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 15 November 2021
  • First Submitted that Met QC Criteria 7 February 2022
  • First Posted 17 February 2022

Study Record Updates

  • Last Update Submitted that Met QC Criteria 23 June 2024
  • Last Update Posted 25 June 2024
  • Last Verified June 2024
I'm interested ...!!